| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
19,335 |
15,783 |
$1.67M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,468 |
5,758 |
$377K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
3,651 |
3,608 |
$284K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
3,953 |
3,255 |
$279K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,481 |
2,432 |
$191K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
2,814 |
2,653 |
$99K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,056 |
1,029 |
$87K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
6,298 |
5,899 |
$84K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
7,519 |
7,275 |
$60K |
| 90671 |
|
705 |
672 |
$52K |
| 99215 |
Prolong outpt/office vis |
426 |
422 |
$52K |
| 92551 |
|
4,639 |
4,542 |
$45K |
| 90670 |
|
1,922 |
1,884 |
$40K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,151 |
2,027 |
$29K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,079 |
1,420 |
$23K |
| 90647 |
|
1,846 |
1,790 |
$22K |
| 90723 |
|
1,125 |
1,079 |
$18K |
| 90656 |
|
1,443 |
1,396 |
$18K |
| 90651 |
|
362 |
354 |
$16K |
| 90633 |
|
1,261 |
1,247 |
$16K |
| 90681 |
|
616 |
593 |
$13K |
| 90686 |
|
1,016 |
989 |
$13K |
| 99070 |
|
4,047 |
3,780 |
$9K |
| 99173 |
|
3,139 |
3,070 |
$8K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
1,992 |
1,883 |
$6K |
| 90710 |
|
155 |
150 |
$6K |
| 0071A |
|
172 |
153 |
$6K |
| 90619 |
|
137 |
132 |
$6K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
335 |
322 |
$5K |
| 99381 |
|
65 |
55 |
$5K |
| 0072A |
|
125 |
123 |
$5K |
| 90734 |
|
181 |
175 |
$5K |
| 90716 |
|
246 |
239 |
$5K |
| 90680 |
|
315 |
312 |
$5K |
| 90620 |
|
80 |
79 |
$4K |
| 90655 |
|
338 |
325 |
$4K |
| 81002 |
|
1,293 |
1,127 |
$4K |
| 0001A |
|
114 |
113 |
$4K |
| 90707 |
|
206 |
197 |
$3K |
| 0002A |
|
91 |
91 |
$3K |
| 90696 |
|
180 |
173 |
$3K |
| 90698 |
|
160 |
157 |
$3K |
| 90700 |
|
209 |
209 |
$3K |
| 90649 |
|
39 |
39 |
$2K |
| 90461 |
|
920 |
867 |
$2K |
| 90691 |
|
44 |
39 |
$1K |
| 90715 |
|
82 |
80 |
$1K |
| 81003 |
|
382 |
330 |
$810.93 |
| 90697 |
|
15 |
14 |
$508.28 |
| 86580 |
|
13 |
13 |
$87.49 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
417 |
307 |
$76.37 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
205 |
192 |
$61.20 |
| J7609 |
Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg |
109 |
100 |
$14.00 |
| 91307 |
|
250 |
232 |
$1.84 |
| 91300 |
|
29 |
29 |
$0.26 |
| 90632 |
|
16 |
16 |
$0.00 |